Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
31.97 USD | -1.33% | -6.32% | +63.00% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 417M |
---|---|---|---|---|---|
Net income 2024 * | -66M | Net income 2025 * | -76M | EV / Sales 2024 * | - |
Net cash position 2024 * | 327M | Net cash position 2025 * | 501M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-8.87
x | P/E ratio 2025 * |
-9.03
x | Employees | 91 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.22% |
Latest transcript on Neurogene Inc.
1 day | +2.01% | ||
1 week | -3.60% | ||
Current month | -5.73% | ||
1 month | +4.28% | ||
3 months | +7.81% | ||
Current year | +67.72% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 31.59 | -2.50% | 13 923 |
24-05-22 | 32.4 | -0.37% | 44,842 |
24-05-21 | 32.52 | -4.38% | 181,911 |
24-05-20 | 34.01 | +2.10% | 96,435 |
24-05-17 | 33.31 | -1.22% | 49,599 |
Delayed Quote Nasdaq, May 23, 2024 at 10:58 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+67.72% | 417M | |
+63.65% | 62.59B | |
-1.75% | 41.18B | |
+44.59% | 40.29B | |
-8.29% | 27.9B | |
+12.29% | 26.21B | |
-21.66% | 19.09B | |
+5.34% | 13.08B | |
+25.37% | 12.26B | |
+28.33% | 12.05B |
- Stock Market
- Equities
- NGNE Stock